Headlands Technologies LLC Purchases Shares of 1,356 LivaNova PLC (NASDAQ:LIVN)

Headlands Technologies LLC bought a new stake in LivaNova PLC (NASDAQ:LIVNFree Report) in the 3rd quarter, Holdings Channel.com reports. The fund bought 1,356 shares of the company’s stock, valued at approximately $72,000.

Several other large investors also recently made changes to their positions in LIVN. Bank of Montreal Can increased its position in shares of LivaNova by 213.3% during the first quarter. Bank of Montreal Can now owns 35,725 shares of the company’s stock worth $2,912,000 after acquiring an additional 24,324 shares in the last quarter. Panagora Asset Management Inc. bought a new stake in shares of LivaNova during the first quarter worth $256,000. Rhumbline Advisers increased its position in shares of LivaNova by 2.1% during the first quarter. Rhumbline Advisers now owns 147,621 shares of the company’s stock worth $12,080,000 after acquiring an additional 2,980 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in shares of LivaNova by 10.5% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,506 shares of the company’s stock worth $1,596,000 after acquiring an additional 1,859 shares in the last quarter. Finally, Yousif Capital Management LLC increased its position in shares of LivaNova by 2.4% during the first quarter. Yousif Capital Management LLC now owns 28,279 shares of the company’s stock worth $2,314,000 after acquiring an additional 661 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Needham & Company LLC restated a “buy” rating and set a $62.00 target price on shares of LivaNova in a report on Friday, November 17th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, LivaNova presently has a consensus rating of “Hold” and a consensus price target of $58.60.

Get Our Latest Analysis on LivaNova

LivaNova Stock Performance

Shares of LIVN opened at $50.70 on Tuesday. LivaNova PLC has a 12 month low of $40.26 and a 12 month high of $59.86. The firm has a fifty day simple moving average of $49.90 and a 200 day simple moving average of $51.12. The stock has a market capitalization of $2.73 billion, a price-to-earnings ratio of 1,014.20 and a beta of 0.86. The company has a current ratio of 3.23, a quick ratio of 2.68 and a debt-to-equity ratio of 0.46.

About LivaNova

(Free Report)

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.

See Also

Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVNFree Report).

Institutional Ownership by Quarter for LivaNova (NASDAQ:LIVN)

Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.